Drug trial aims to shield kidneys from heart surgery damage
NCT ID NCT05010460
Summary
This study tested whether giving the drug roxadustat before heart bypass surgery could prevent a common complication called acute kidney injury. About 98 patients scheduled for non-emergency bypass surgery were randomly assigned to receive either roxadustat or a placebo before their operation. The goal was to see if the drug, which helps tissues tolerate low oxygen levels, could reduce kidney damage after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY BYPASS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Hospital
Beijing, Beijing Municipality, 100730, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Conditions
Explore the condition pages connected to this study.